34 results on '"Ang, M-K."'
Search Results
2. 227MO Characterization of minimal residual disease (MRD) post-radiotherapy (RT) in nasopharyngeal carcinoma (NPC) patients identifies a favorable subgroup with low risk of relapse
3. P2.13-02 Dynamic Tracking of Bespoke Circulating Tumour DNA During Multi-Modality Therapy for Locally Advanced NSCLC (LA-NSCLC)
4. 652O Randomized phase III VANCE study: Gemcitabine and carboplatin (GC) followed by Epstein Barr virus-specific autologous cytotoxic T lymphocytes (EBV-CTL) versus the same chemotherapy as first-line treatment for advanced nasopharyngeal carcinoma (NPC)
5. EP16.03-036 Clinical and Genomic Features of HER2 exon 20 Insertion Mutations in East Asian NSCLC
6. 1221P Outcomes of EGFR-mutant NSCLC patients with de novo brain metastases by upfront treatment
7. 911P Post-radiotherapy (RT) Epstein-Barr virus (EBV) DNA dynamics identifies optimal timepoint for stratification of high-risk nasopharyngeal carcinoma (NPC)
8. 192P ddPCR versus plasma NGS in detecting clearance of plasma EGFR mutations
9. 266O Combination ipilimumab and nivolumab in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Updated efficacy and safety analysis of NCT03097939
10. Nuclear expression of MATK is a novel marker of type II enteropathy-associated T-cell lymphoma
11. Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers
12. Docetaxel is effective in heavily pretreated patients with disseminated nasopharyngeal carcinoma
13. Clinicopathological characteristics and outcome of advanced ROS1-positive non-small cell lung cancer in Asian patients
14. Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Singapore
15. Somatostatin receptor 2 expression and clinical significance in pulmonary lymphoepithelioma-like carcinoma
16. T790M co-exists with other secondary resistance mechanisms in EGFR mutation positive NSCLC and are associated with inferior outcomes
17. 523P - Real world data on epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) use in advanced/metastatic non-small cell lung cancer (NSCLC) with EGFR mutations in Singapore
18. 1921P - Somatostatin receptor 2 expression and clinical significance in pulmonary lymphoepithelioma-like carcinoma
19. 339TiP Phase III study of afatinib vs placebo as adjuvant therapy after chemo-radiotherapy (CRT) in primary unresected patients with locoregionally advanced (LA) head and neck squamous cell carcinoma (HNSCC) in Asia: LUX-Head & Neck 4 (LUX-H&N4)
20. 478TiP A phase II, multicenter, four-cohort study of oral cMET inhibitor capmatinib (INC280) in patients with EGFR wild-type, advanced NSCLC who have received one or two prior lines of systemic therapy for advanced/metastatic disease
21. The phenomenon of accommodation in the ventricular myocardium
22. 131P - T790M co-exists with other secondary resistance mechanisms in EGFR mutation positive NSCLC and are associated with inferior outcomes
23. Different cellular p16INK4a localisation may signal different survival outcomes in head and neck cancer
24. Different cellular p16INK4a localisation may signal different survival outcomes in head and neck cancer.
25. Prevalence and antibiotic susceptibility of thermophilic Campylobacter species on beef, mutton, and chicken carcasses in Istanbul, Turkey
26. Improved survival of advanced lung cancer in Singapore over the past decade
27. 145P Clinicopathological characteristics and outcome of advanced ROS1-positive non-small cell lung cancer in Asian patients.
28. Pan-Asian adaptation of the EHNS-ESMO-ESTRO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with squamous cell carcinoma of the head and neck.
29. A Phase 1 dose-finding and pharmacodynamic study of rapamycin in combination with bevacizumab in patients with unresectable hepatocellular carcinoma.
30. Medical management of ascites in hepatic cirrhosis.
31. Diphenylhydantoin (Dilantin) neurotoxicity--a deceptive syndrome.
32. Hepatic coma complicating cirrhosis of the liver in Schistosomiasis japonica.
33. An experimental study of some effects of hypoxia and respiratory acidosis on the mammalian heart.
34. Chronic obstructive pulmonary disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.